Historique de carrière de Saeed Motahari
Anciens postes connus de Saeed Motahari
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INSYS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/04/2017 | 14/04/2019 |
| Directeur Général | 17/04/2017 | 14/04/2019 | |
| President | 17/04/2017 | 14/04/2019 | |
| ABBVIE INC. | Corporate Officer/Principal | - | - |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Corporate Officer/Principal | 22/05/2014 | - |
Formation de Saeed Motahari
| Concordia University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Canada | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |
INSYS Therapeutics, Inc.
 INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
- Bourse
- Insiders
- Saeed Motahari
- Expérience
